Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)

BACKGROUND: Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, often demonstrating resistance to multimodal therapeutic approaches. The median survival of ATC patients after initial diagnosis was reported to be < 6 months due to the rapid progression of disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoda, Naoyoshi, Sugitani, Iwao, Higashiyama, Takuya, Hara, Hisato, Ito, Ken-ichi, Kammori, Makoto, Sugino, Kiminori, Suzuki, Shinichi, Toda, Kazuhisa, Yoshida, Akira, Miyauchi, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474467/
https://www.ncbi.nlm.nih.gov/pubmed/26091846
http://dx.doi.org/10.1186/s12885-015-1490-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474467/
https://www.ncbi.nlm.nih.gov/pubmed/26091846
http://dx.doi.org/10.1186/s12885-015-1490-8

Ejemplares similares